These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 11155296)
21. Plasma homocysteine, methylenetetrahydrofolate reductase genotypes, and age at onset of symptoms of myocardial ischemia. Mager A; Battler A; Birnbaum Y; Magal N; Shohat M Am J Cardiol; 2002 Apr; 89(8):919-23. PubMed ID: 11950428 [TBL] [Abstract][Full Text] [Related]
22. Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease. Andreassi MG; Botto N; Cocci F; Battaglia D; Antonioli E; Masetti S; Manfredi S; Colombo MG; Biagini A; Clerico A Hum Genet; 2003 Feb; 112(2):171-7. PubMed ID: 12522558 [TBL] [Abstract][Full Text] [Related]
23. [Correlation analysis between plasma homocysteine level and polymorphism of homocysteine metabolism related enzymes in ischemic cerebrovascular or cardiovascular diseases]. Zhang G; Dai C Zhonghua Xue Ye Xue Za Zhi; 2002 Mar; 23(3):126-9. PubMed ID: 12015064 [TBL] [Abstract][Full Text] [Related]
24. Methylenetetrahydrofolate reductase and apolipoprotein E polymorphisms are independent risk factors for coronary heart disease in Japanese: a case-control study. Ou T; Yamakawa-Kobayashi K; Arinami T; Amemiya H; Fujiwara H; Kawata K; Saito M; Kikuchi S; Noguchi Y; Sugishita Y; Hamaguchi H Atherosclerosis; 1998 Mar; 137(1):23-8. PubMed ID: 9568733 [TBL] [Abstract][Full Text] [Related]
25. The C677T methylenetetrahydrofolate reductase polymorphism influences the homocysteine-lowering effect of hormone replacement therapy. Brown CA; McKinney KQ; Young KB; Norton HJ Mol Genet Metab; 1999 May; 67(1):43-8. PubMed ID: 10329022 [TBL] [Abstract][Full Text] [Related]
26. Plasma homocysteine and the methylenetetrahydrofolate reductase C677T gene variant: lack of association with schizophrenia. Virgos C; Martorell L; Simó JM; Valero J; Figuera L; Joven J; Labad A; Vilella E Neuroreport; 1999 Jul; 10(10):2035-8. PubMed ID: 10424670 [TBL] [Abstract][Full Text] [Related]
28. The C677T thermolabile variant of methylene tetrahydrofolate reductase on homocysteine, folate and vitamin B12 in a hemodialysis center. Trimarchi H; Genoud V; Schiel A; Castañon M; Freixas E; Diaz ML; Schropp J; Martino D; Pereyra H; Kordich L Medicina (B Aires); 2002; 62(2):149-53. PubMed ID: 12038037 [TBL] [Abstract][Full Text] [Related]
29. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Ma J; Stampfer MJ; Hennekens CH; Frosst P; Selhub J; Horsford J; Malinow MR; Willett WC; Rozen R Circulation; 1996 Nov; 94(10):2410-6. PubMed ID: 8921781 [TBL] [Abstract][Full Text] [Related]
30. Polymorphism in methylenetetrahydrofolate reductase gene: its impact on plasma homocysteine levels and carotid atherosclerosis in ESRD patients receiving hemodialysis. Lim PS; Hung WR; Wei YH Nephron; 2001 Mar; 87(3):249-56. PubMed ID: 11287760 [TBL] [Abstract][Full Text] [Related]
31. Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population. Nair KG; Nair SR; Ashavaid TF; Dalal JJ; Eghlim FF J Assoc Physicians India; 2002 May; 50 Suppl():9-15. PubMed ID: 12186157 [TBL] [Abstract][Full Text] [Related]
32. Major gene evidence after MTHFR-segregation analysis of serum homocysteine in families of patients undergoing coronary arteriography. Jee SH; Song KS; Shim WH; Kim HK; Suh I; Park JY; Won SY; Beaty TH Hum Genet; 2002 Aug; 111(2):128-35. PubMed ID: 12189485 [TBL] [Abstract][Full Text] [Related]
33. Comparison of homocysteinemia and MTHFR 677CT polymorphism with Framingham Coronary Heart Risk Score. Gariglio L; Riviere S; Morales A; Porcile R; Potenzoni M; Fridman O Arch Cardiol Mex; 2014; 84(2):71-8. PubMed ID: 24793554 [TBL] [Abstract][Full Text] [Related]
34. MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis. Klerk M; Verhoef P; Clarke R; Blom HJ; Kok FJ; Schouten EG; JAMA; 2002 Oct 23-30; 288(16):2023-31. PubMed ID: 12387655 [TBL] [Abstract][Full Text] [Related]
36. Identification of six methylenetetrahydrofolate reductase (MTHFR) genotypes resulting from common polymorphisms: impact on plasma homocysteine levels and development of coronary artery disease. Meisel C; Cascorbi I; Gerloff T; Stangl V; Laule M; Müller JM; Wernecke KD; Baumann G; Roots I; Stangl K Atherosclerosis; 2001 Feb; 154(3):651-8. PubMed ID: 11257266 [TBL] [Abstract][Full Text] [Related]
37. The VITA project: C677T mutation in the methylene-tetrahydrofolate reductase gene and risk of venous thromboembolism. Tosetto A; Missiaglia E; Frezzato M; Rodeghiero F Br J Haematol; 1997 Jun; 97(4):804-6. PubMed ID: 9217179 [TBL] [Abstract][Full Text] [Related]
38. Relation of a common mutation in methylenetetrahydrofolate reductase to plasma homocysteine and early onset coronary artery disease. Dunn J; Title LM; Bata I; Johnstone DE; Kirkland SA; O'Neill BJ; Zayed E; MacDonald MC; Dempsey G; Nassar B Clin Biochem; 1998 Mar; 31(2):95-100. PubMed ID: 9622772 [TBL] [Abstract][Full Text] [Related]
39. Correlation between the 677C>T polymorphism in the methylene tetrahydrofolate reductase gene and serum homocysteine levels in coronary heart disease. Chen YY; Wang BN; Yu XP Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27051002 [TBL] [Abstract][Full Text] [Related]
40. Hyperhomocysteinemia, MTHFR C677T genotype and low folate levels: a risk combination for acute coronary disease in a Portuguese population. Araújo F; Lopes M; Gonçalves L; Maciel MJ; Cunha-Ribeiro LM Thromb Haemost; 2000 Mar; 83(3):517-8. PubMed ID: 10744169 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]